Physician profile
Gary D Polan
NPI 1942368972
$7,504.64
in general payments reported to CMS, 2019-2025
14 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 97% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $539 · 2021: $689 · 2022: $1,238 · 2023: $1,394 · 2024: $1,319 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572 · Entertainment: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,572.03 |
| Entertainment | $285.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,104.17 | 2019-2025 | Dailies Total1, Precision 1, Total30 |
| Abbvie INC. | $923.45 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $680.63 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $569.83 | 2024-2025 | Miebo, Xiidra, Infuse |
| Optos, INC. | $414.06 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $389.88 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Glaukos Corporation | $349.85 | 2021-2025 | Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $231.49 | 2019-2020 | |
| Staar Surgical Company | $206.38 | 2019 | |
| Shire North American Group INC | $169.43 | 2019 | |
| Harrow Eye, LLC | $149.92 | 2025 | Vevye |
| Coopervision INC. | $136.50 | 2021-2025 | Misight Contact Lens, Myday Contact Lens |
| Regeneron Healthcare Solutions, INC. | $119.16 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $59.89 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Polan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.